Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial
EndocrinologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Diabetes care
- Publicado em
- 1 dez 2023
- Citações
- 53
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Safety and Efficacy of Sustained Automated Insulin Delivery Compared With Sensor and Pump Therapy in Adults With Type 1 Diabetes at High Risk for Hypoglycemia: A Randomized Controlled Trial
Eric Renard, Michael Joubert, Orianne Villard, Bleuenn Dreves, Yves Reznik, Anne Farret, Jérôme Place, Marc Breton, Boris P Kovatchev, iDCL Trial Research Group
Descritores MeSH
- Hypoglycemia
- Diabetes Mellitus, Type 1
- Humans
- Hypoglycemic Agents
- Insulin
- Insulin Infusion Systems
- Blood Glucose Self-Monitoring
- Adult
- Insulin, Regular, Human
- Blood Glucose
Veja também
Estudos relacionados
- A Meta-Analysis of Randomized Trial Outcomes for the t:slim X2 Insulin Pump with Control-IQ Technology in Youth and Adults from Age 2 to 72
- Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes
- Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial
- The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations